AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Moore, JE Buckley, TC Millar, BC Gibson, P Cannon, G Egan, C Cosgrove, H Stanbridge, S Anzai, T Matsuda, M Murphy, PG
Citation: Je. Moore et al., Molecular surveillance of the incidence of Taylorella equigenitalis and Pseudomonas aeruginosa from horses in Ireland by sequence-specific PCR [SS-PCR], EQUINE V J, 33(3), 2001, pp. 319-322

Authors: Taylor, AH Fox-Robichaud, AE Egan, C Dionne, J Lawless, DE Raymond, J Romney, J Wong, NCW
Citation: Ah. Taylor et al., Oestradiol decreases rat apolipoprotein AI transcription via promoter siteB, J MOL ENDOC, 25(2), 2000, pp. 207-219

Authors: Egan, C Grinde, E Dupre, A Roth, BL Hake, M Teitler, M Herrick-Davis, K
Citation: C. Egan et al., Agonist high and low affinity state ratios predict drug intrinsic activityand a revised ternary complex mechanism at serotonin 5-HT2A and 5-HT2C receptors, SYNAPSE, 35(2), 2000, pp. 144-150

Authors: Glennon, RA Dukat, M Grella, B Hong, SS Costantino, L Teitler, M Smith, C Egan, C Davis, K Mattson, MV
Citation: Ra. Glennon et al., Binding of beta-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D-2) and benzodiazepine receptors, DRUG AL DEP, 60(2), 2000, pp. 121-132

Authors: Dowd, CS Herrick-Davis, K Egan, C DuPre, A Smith, C Teitler, M Glennon, RA
Citation: Cs. Dowd et al., 1-[4-(3-phenylalkyl)phenyl]-2-aminopropanes as 5-HT2A partial agonists, J MED CHEM, 43(16), 2000, pp. 3074-3084

Authors: Khorana, N Bondarev, M Dukat, M Herrick-Davis, K Egan, C DuPre, A Smith, C Teitler, M Glennon, RA
Citation: N. Khorana et al., Binding of spiperone analogs at 5-HT2A serotonin receptors, MED CHEM RE, 9(9), 1999, pp. 657-667

Authors: Hong, S Dukat, M Teitler, M Egan, C Dupre, A Herrick-Davis, K Glennon, RA
Citation: S. Hong et al., 5,8-dimethoxyharmalan: Actions at 5-HT2a serotonin receptors, MED CHEM RE, 9(6), 1999, pp. 374-388

Authors: Egan, C Pang, A Durda, D Cheng, HC Wang, JH Fujita, DJ
Citation: C. Egan et al., Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530, ONCOGENE, 18(5), 1999, pp. 1227-1237

Authors: Berguer, R Bravo, CN Bowyer, M Egan, C Knolmayer, T Ferrick, D
Citation: R. Berguer et al., Major surgery suppresses maximal production of helper T-cell type 1 cytokines without potentiating the release of helper T-cell type 2 cytokines, ARCH SURG, 134(5), 1999, pp. 540-544

Authors: Lee, M Kemp, JA Canning, A Egan, C Tataronis, G Farraye, FA
Citation: M. Lee et al., A randomized controlled trial of an enhanced patient compliance program for Helicobacter pylori therapy, ARCH IN MED, 159(19), 1999, pp. 2312-2316
Risultati: 1-10 |